Development of a Retinopathy of Prematurity Activity Scale and Clinical Outcome Measures for Use in Clinical Trials-Reference-Cited by-同舟云学术

Development of a Retinopathy of Prematurity Activity Scale and Clinical Outcome Measures for Use in Clinical Trials

Published:2019-03-01 Issue:3 Volume:137 Page:305
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Smith Lois E. H.¹,Hellström Ann²,Stahl Andreas³,Fielder Alistair⁴,Chambers Wiley⁵,Moseley Jane⁶,Toth Cynthia⁷,Wallace David⁸,Darlow Brian A.⁹,Aranda Jacob V.¹⁰,Hallberg Boubou¹¹,Davis Jonathan M.¹²¹³,

Affiliation:

1. Department of Ophthalmology, Harvard Medical School, Boston Children’s Hospital, Boston, Massachusetts

2. Department of Clinical Neuroscience at Institute of Neuroscience and Physiology, University of Göteborg, Göteborg, Sweden

3. Department of Ophthalmology, University of Freiburg, Freiburg, Germany

4. Department of Optometry & Visual Science, City University of London, London, United Kingdom

5. Division of Transplant and Ophthalmology Products, US Food and Drug Administration, Bethesda, Maryland

6. Human Medicines Research and Development Support Division, European Medicines Agency, London, United Kingdom

7. Department of Ophthalmology, Duke University, Durham, North Carolina

8. Department of Ophthalmology, Indiana University, Indianapolis

9. Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand

10. Department of Ophthalmology, State University of New York Downstate Medical Center, Brooklyn

11. Division of Paediatrics, Karolinska University Hospital, Stockholm, Sweden

12. The Floating Hospital for Children, Tufts Medical Center, Boston, Massachusetts

13. Department of Pediatrics, Tufts University School of Medicine, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Link

http:///jamaophthalmology/article-pdf/137/3/305/17326545/jamaophthalmology_smith_2018_sc_180002.pdf

Reference19 articles.

1. The International Classification of Retinopathy of Prematurity revisited.;International Committee for the Classification of Retinopathy of Prematurity;Arch Ophthalmol,2005

2. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010.;Blencowe;Pediatr Res,2013

3. Association between oxygen saturation targeting and death or disability in extremely preterm infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration.;Askie;JAMA,2018

4. Anti-vascular endothelial growth factor therapy for primary treatment of type 1 retinopathy of prematurity: a report by the American Academy of Ophthalmology.;VanderVeen;Ophthalmology,2017

5. Revised indications for the treatment of retinopathy of prematurity: results of the Early Treatment for Retinopathy of Prematurity randomized trial.;Early Treatment for Retinopathy of Prematurity Cooperative Group;Arch Ophthalmol,2003

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity;JAMA Network Open;2024-04-30

2. Performing clinical drug trials in acute and critically ill neonates and children;Essentials of Translational Pediatric Drug Development;2024

3. Preterm infant retinal OCT markers of perinatal health and retinopathy of prematurity;Frontiers in Pediatrics;2023-09-21

4. Telemedicine retinopathy of prematurity severity score (TeleROP-SS) versus modified activity score (mROP-ActS) retrospective comparison in SUNDROP cohort;Scientific Reports;2023-09-14

5. Nailfold Capillaroscopy: A Promising, Noninvasive Approach to Predict Retinopathy of Prematurity;The Journal of Pediatrics;2023-08